Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTGS2 | P35354 | 14/20 | 0.80 |
| ▸ | PTGS1 | P23219 | 10/20 | 0.80 |
| ▸ | MT-CO2 | P00403 | 3/20 | 0.71 |
| ▸ | CA12 | O43570 | 1/20 | 0.71 |
| ▸ | CA1 | P00915 | 1/20 | 0.71 |
| ▸ | CA2 | P00918 | 1/20 | 0.71 |
| ▸ | LMNA | P02545 | 1/20 | 0.71 |
| ▸ | CA3 | P07451 | 1/20 | 0.71 |
| ▸ | ADRB2 | P07550 | 1/20 | 0.71 |
| ▸ | ADRB1 | P08588 | 1/20 | 0.71 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.71 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.71 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.71 |
| ▸ | ADRA2B | P18089 | 1/20 | 0.71 |
| ▸ | CA4 | P22748 | 1/20 | 0.71 |
| ▸ | CA6 | P23280 | 1/20 | 0.71 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.71 |
| ▸ | PDE4A | P27815 | 1/20 | 0.71 |
| ▸ | ADORA1 | P30542 | 1/20 | 0.71 |
| ▸ | CA5A | P35218 | 1/20 | 0.71 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5422595 | 0.91 | PTGS2 (0.77) | PTGS2PTGS1MT-CO2CA12CA1 | |
| Sulfamide SCHEMBL4638912 | 0.90 | PTGS2 (0.81) | PTGS2PTGS1MT-CO2CA12CA1 | |
| SCHEMBL2277199 | 0.89 | PTGS2 (1.00) | PTGS2PTGS1MT-CO2CA12CA1 | |
| Sulfuric Acid SCHEMBL6263326 | 0.89 | PTGS2 (0.77) | PTGS2PTGS1MT-CO2CA12CA1 | |
| Sulfuric Acid SCHEMBL6263325 | 0.89 | PTGS2 (0.77) | PTGS2PTGS1MT-CO2CA12CA1 | |
| SCHEMBL28961699 | 0.86 | PTGS2 (0.79) | PTGS2PTGS1MT-CO2CA12CA1 | |
| SCHEMBL14267653 | 0.84 | PTGS2 (0.77) | PTGS2PTGS1MT-CO2CA12CA1 | |
| SCHEMBL5703656 | 0.84 | PTGS2 (0.77) | PTGS2PTGS1MT-CO2CA12CA1 | |
| SCHEMBL8343796 | 0.84 | PTGS2 (0.73) | PTGS2PTGS1MT-CO2CA12CA1 | |
| SCHEMBL31213518 | 0.84 | PTGS2 (0.60) | PTGS2PTGS1MT-CO2CA12CA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-105130919-B | Method and equipment for preparing 4-(5-methyl-3-phenyl-4-isoxazolyl) benzenesulfonyl chloride | 江苏嘉逸医药有限公司 | 2017-04-19 | — | — | CN | claimed |
| CN-104557756-B | Synthetic method of parecoxib sodium impurity | 成都克莱蒙医药科技有限公司 | 2017-02-22 | — | — | CN | claimed |
| CN-105130919-A | Method and equipment for preparing 4-(5-methyl-3-phenyl-4-isoxazolyl) benzenesulfonyl chloride | JIANGSU YIJIA MEDICINE CO LTD | 2015-12-09 | — | — | CN | claimed |
| CN-104250232-A | Preparation method of parecoxib sodium | SICHUAN WEITUO BIOLOG PHARMACEUTICAL CO LTD | 2014-12-31 | — | — | CN | claimed |
| US-20050272787-A1 | Process for preparing crystalline form A of valdecoxib | DR. REDDY'S LABORATORIES, INC. | 2005-12-08 | — | — | US | claimed |
| CN-109734681-A | SC 69124 sodium impurity and preparation method thereof | 四川蓝励医药科技有限公司 | 2019-05-10 | — | — | CN | disclosed |
| CN-105130919-B | Method and equipment for preparing 4-(5-methyl-3-phenyl-4-isoxazolyl) benzenesulfonyl chloride | 江苏嘉逸医药有限公司 | 2017-04-19 | — | — | CN | disclosed |
| CN-105130919-A | Method and equipment for preparing 4-(5-methyl-3-phenyl-4-isoxazolyl) benzenesulfonyl chloride | JIANGSU YIJIA MEDICINE CO LTD | 2015-12-09 | — | — | CN | disclosed |
| CN-104250232-A | Preparation method of parecoxib sodium | SICHUAN WEITUO BIOLOG PHARMACEUTICAL CO LTD | 2014-12-31 | — | — | CN | disclosed |
| US-20050272787-A1 | Process for preparing crystalline form A of valdecoxib | DR. REDDY'S LABORATORIES, INC. | 2005-12-08 | — | — | US | disclosed |
| US-20050182113-A1 | Method for preparing diaryl-substituted isoxazole compounds | DR. REDDY'S LABORATORIES LTD. (IN) | 2005-08-18 | — | — | US | disclosed |
| EP-1550658-A1 | Method for preparing 3,4-diphenyl-substituted isoxazole compounds | Dr. Reddy's Laboratories Ltd. (IN) | 2005-07-06 | — | — | EP | disclosed |
| CN-1578774-A | Process for preparing benzenesulfonyl compounds | PHARMACIA CORP (US) | 2005-02-09 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050182113-A1 | Method for preparing diaryl-substituted isoxazole compounds | CYP2C9, CYP3A7, CYP3A5 | PTGS2 75/4885PTGS1 94/4885MT-CO2 430/4885 |
| US-20050272787-A1 | Process for preparing crystalline form A of valdecoxib | TTR, CYP3A4, CYP2F1 | PTGS2 4394/4885PTGS1 4304/4885MT-CO2 2699/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.